IRONWOOD PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Ironwood Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 160M shares, a 2.45% increase year-over-year.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 155M shares, a 0.69% increase from 2022.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 154M shares, a 4.86% decline from 2021.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 162M shares, a 1.77% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 160M +3.82M +2.45% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 159M +3.65M +2.35% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 158M +3.25M +2.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 155M +1.07M +0.69% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 156M +2.82M +1.84% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 155M +2.06M +1.35% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 154M -3.37M -2.14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 154M -7.88M -4.86% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 153M -9.68M -5.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 153M -8.64M -5.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 158M -3.15M -1.95% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 162M +2.82M +1.77% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 163M +2.9M +1.81% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 162M +2.54M +1.59% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 161M +2.59M +1.64% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 159M +3.4M +2.18% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 160M +3.41M +2.18% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 159M +3.56M +2.28% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 158M +3.42M +2.21% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 156M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 156M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 156M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 155M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2013 121M +13.5M +12.6% Jul 1, 2013 Sep 30, 2013 10-Q 2013-10-28
Q3 2012 107M +7.09M +7.08% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 107M +7.4M +7.43% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 104M +4.68M +4.72% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-10
Q4 2011 99.9M Oct 1, 2011 Dec 31, 2011 10-K 2012-02-29
Q3 2011 100M +2.25M +2.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 99.7M +2.03M +2.08% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 99.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 97.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 97.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.